SBI Securities’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.5K Buy
325
+197
+154% +$32.8K ﹤0.01% 1164
2026
Q1
$26.9K Buy
128
+7
+6% +$1.76K ﹤0.01% 1335
2025
Q4
$34.4K Hold
121
﹤0.01% 1239
2025
Q3
$37.4K Sell
121
-7
-5% -$2.19K ﹤0.01% 1198
2025
Q2
$40.2K Sell
128
-2
-2% -$577 ﹤0.01% 1129
2025
Q1
$34.1K Sell
130
-9
-6% -$2.44K ﹤0.01% 1125
2024
Q4
$36.3K Buy
+139
New +$35K ﹤0.01% 1083

Other funds holding PODD

SBI Securities's PODD Position: Q2 2026 in Review

SBI Securities increased its Insulet (PODD) stake by 154% in Q2 2026, buying an estimated $32.8K and bringing the position to 325 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1164.

SBI Securities first reported a position in PODD in Q4 2024 and has held it in 7 quarters since. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • SBI Securities held 325 shares of Insulet worth $49.5K as of Q2 2026.
  • SBI Securities bought 197 Insulet shares in Q2 2026, an estimated $32.8K.
  • Insulet made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1164 holding.
  • SBI Securities first reported a position in Insulet in Q4 2024 and has held it in 7 quarters since.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.